ArticleACS organic & inorganic Au2022
Alternatives to Iridium: A Polyaza[7]helicene as a Strongly Reductive Visible Light Photoredox Catalyst.
Article in ACS organic & inorganic Au, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pyrene-4,5-dione as a Visible-Light Organic Photocatalyst for Photooxidation, Photoredox, Energy Transfer, and Hydrogen Atom Transfer Reactions.ACS organic & inorganic Au · 2026Article
- Mechanistic investigations of polyaza[7]helicene in photoredox and energy transfer catalysis.Beilstein journal of organic chemistry · 2024Article
- Advances in Organic and Inorganic Photoredox Catalysis.ACS organic & inorganic Au · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of a readily accessible polyazahelicene as a strongly reducing metal-free alternative to the commonly used precious metal based photoredox catalysts is demonstrated. An improved two-step synthesis of the catalyst is described, and its photophysical properties with respect to its use as a photoredox catalyst are evaluated. Its activity under visible light irradiation is proven by application in two double radical light-driven multicomponent reactions. The azahelicene gave comparable results to an iridium-based catalyst originally used for the same transformations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.